Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke

Overview

Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants who have had a stroke at least 6 months before enrolment and experience persistent balance and gait deficits. Participants will be randomized into three groups: (1) robotic balance training with active brain stimulation, (2) robotic balance training with sham brain stimulation, and (3) standard-of-care rehabilitation. The study will involve 15 training sessions over 5 weeks, with assessments conducted at baseline, post-training, and two months post-training to evaluate balance recovery and retention. The primary focus is understanding how this intervention affects brain and muscle activity during balance tasks and how these changes translate into functional improvements in clinical outcome measures of balance function. Additionally, participant feedback on brain stimulation and exercise engagement will be collected to inform future studies. The findings may guide the development of personalized training protocols and contribute to broader rehabilitation strategies.

Interventions

• Device Combined (Robotic balance training and high-definition transcranial direct current stimulation)
  The robotic platform will train the participants to maintain dynamic balance in the sagittal and transverse planes (mediolateral and anterior-posterior directions) and engage in core stability and trunk control with seated balance exercises. In addition, high-definition transcranial direct current stimulation (HD-tDCS) will be used as an adjuvant to robotic balance training by priming the corticospinal circuits.
• Other Standard of Care Balance Training
  Participants in this group will receive a standard-of-care balance training (dose matched to the experimental group) administered by the Physical therapist.

Primary outcome measures

• Berg Balance Scale (BBS) [Time frame: Baseline, post 5-week training, 2-month follow-up]

Secondary outcome measures (9)

• Functional Gait Assessment (FGA) [Time frame: Baseline, post 5-week training, and 2-month follow-up]
• Mini Balance Evaluation Systems Test (MBT) [Time frame: Baseline, post 5-week training, and 2-month follow-up]
• Trunk Impairment Scale (TIS) [Time frame: Baseline, post 5-week training, and 2-month follow-up]
• Center of Pressure (COP) Displacement [Time frame: Baseline, post 5-week training, and 2-month follow-up]
• TMS-evoked EEG Potentials (TEP) [Time frame: Baseline, post 5-week training, and 2-month follow-up]
• EEG Corticocortical Functional Connectivity [Time frame: Baseline, post 5-week training, and 2-month follow-up]
• EEG-to-EMG Corticomuscular Connectivity [Time frame: Baseline, post 5-week training, and 2-month follow-up.]
• EMG Muscle Coactivation [Time frame: Baseline, post 5-week training, and 2-month follow-up.]
• Diffusion Tensor Imaging (DTI) Fractional Anisotropy [Time frame: Baseline and post-5-week training]

Eligibility criteria

Inclusion criteria

• Aged between 18-75 years
• Diagnosed with a cortical/subcortical ischemic stroke at least 6 months before the screening, as confirmed by the neurological exam or an MRI.
• Have complaints of impaired balance and poor postural control determined by a BBS score of ≤50.
• Ability to stand upright with or without support for at least 20 seconds
• Ability to walk with or without a walking aid for at least ten meters
• Not planning to change medication in the next four months
• Minimum Cognitive Ability to understand the verbal instructions and comply with the study procedures, as determined by the University of California, San Diego, Brief Assessment of Capacity to Consent Instrument (UBACC).

Exclusion criteria

• Currently undergoing any regular physical therapy program or research studies focusing on balance functions.
• Having a brainstem stroke.
• Contraindication for MRI scan (presence of metal implants, claustrophobia)
• Affected by the peripheral nerve injury, neuromuscular conditions, or orthopedic issues of lower limbs before stroke, or have any persistent pain or difficulty maintaining blood pressure while upright.
• Have a scalp or skin condition (e.g., psoriasis or eczema) \* on the scalp near the stimulation site
• Having severe visual impairment (e.g., spatial neglect) or hearing problems that may affect study compliance
• Any other neurological injury or psychiatric conditions (e.g., severe anxiety or schizophrenia etc.)
• Contraindications to MRI, including the presence of non-titanium metallic implants, claustrophobia, etc.
• Not be pregnant or thinking of becoming pregnant
• Diagnosed with alcohol or substance abuse in the last 3 years
• Contraindications to TMS, including the presence of metallic implants in the head and a history of seizures or medication-resistant epilepsy or ongoing use of anti-seizure/seizure threshold-lowering medications.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation

Randomized

Model

Parallel assignment

Masking

Triple blind

Primary purpose

Treatment

Study locations

United States · 1 center

• Kessler Foundation — West Orange

Identifiers

NCT: NCT07113041 · R-1279-24 · 90REGE0025-01-00

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗